Cargando…
Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection
Purpose: To study the association between pretreatment serum hepatitis B viral (HBV) DNA copy numbers and clinical outcome of non-small cell lung cancer (NSCLC) patients with chronic HBV infection. Patients and methods: We retrospectively evaluated the medical records of NSCLC HBV (+) patients betwe...
Autores principales: | Fu, Yumei, Yang, Xiaoyi, Liang, Huifen, Wu, Xingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549665/ https://www.ncbi.nlm.nih.gov/pubmed/31213920 http://dx.doi.org/10.2147/CMAR.S198714 |
Ejemplares similares
-
Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990) -
Viral Biomarkers in Chronic HBeAg Negative HBV Infection
por: Hadziyannis, Emilia, et al.
Publicado: (2018) -
Serum hepatitis B virus (HBV) DNA levels at different stages of clinical course in patients with chronic HBV infection in an endemic area.
por: Heo, Jeong, et al.
Publicado: (2003) -
HBV‐RNA Co‐amplification May Influence HBV DNA Viral Load Determination
por: Maasoumy, Benjamin, et al.
Publicado: (2020) -
New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)